Group 1 - Recent demand for home testing and antiviral medications has surged, with COVID-19 antigen search demand in Beijing, Shanghai, Guangzhou, and Shenzhen increasing by 3-5 times compared to the previous week [1] - Home testing service orders on Meituan have increased by 30% year-on-year over the past four days, while orders for COVID-related antiviral medications have more than doubled compared to the previous week [1] - Meituan Health has launched a special public welfare program in collaboration with Wanfang Biological and medical device merchants, allowing users to purchase COVID-19 antigen test kits for just one cent, targeting high-demand cities [1] Group 2 - Guangzhou Pharmaceutical Group's subsidiary, Baiyunshan and Huang Zhong Medicine, reports that current production capacity can meet market demand for antiviral drugs [2] - The company has collaborated with academic experts for over ten years, discovering that Banlangen has multi-target antiviral properties and can help regulate excessive immune responses [2] - The formulation of Kouyanqing granules, which includes various traditional Chinese medicinal ingredients, is effective in treating oral and throat diseases, potentially alleviating symptoms of pharyngitis [2]

Group 1 - The monitoring data from the Chinese Center for Disease Control indicates an increasing trend in the positive rate of COVID-19 tests during the monitoring period from March 31 to May 4, with southern provinces showing higher rates than northern provinces [1] - There has been a significant increase in the sales of related medications both online and offline, with a notable rise in demand for COVID-19 antigen tests and related medications, as well as cough and anti-inflammatory drugs [2] - The supply of COVID-19 related medications is sufficient across online platforms, and consumers are advised not to hoard medications unnecessarily [2] Group 2 - The public is advised to maintain good hygiene practices and to seek medical attention if experiencing severe symptoms related to COVID-19, with a recommendation for high-risk groups to actively receive the latest available COVID-19 vaccines [3] - The increase in demand for medications that address both COVID-19 prevention and throat symptom relief has been noted, indicating a shift in consumer needs [2][3]

Group 1 - The core viewpoint indicates a resurgence of COVID-19 cases in China, with a notable increase in positive rates among emergency and hospitalized patients, leading to a surge in demand for related medications [1][2] - The COVID-19 positive rate in emergency visits rose from 7.5% to 16.2%, and in hospitalized cases from 3.3% to 6.3% during the monitoring period from March 31 to May 4 [1] - The demand for COVID-19 medications has significantly increased, with online searches for related drugs on platforms like Meituan doubling in recent days, particularly in cities like Guangzhou and Shenzhen [3][6] Group 2 - Sales of certain anti-fever and cold medications have increased by 2 to 5 times year-on-year, indicating a heightened consumer interest in these products [6][7] - Specific products, such as Baiyunshan Banlangen, have become popular for their multifunctional benefits in treating COVID-19 and throat symptoms, reflecting a shift in consumer preferences towards effective home remedies [6][7] - Pharmacies report that the supply of various medications is sufficient, and consumers are advised to purchase as needed rather than stockpiling [6][7]